125 related articles for article (PubMed ID: 35906120)
1. Expression level of immune checkpoint inhibitory factors in preeclampsia.
Madadi S; Mohammadinejad S; Alizadegan A; Hojjat-Farsangi M; Dolati S; Samadi Kafil H; Jadidi-Niaragh F; Soltani-Zangbar MS; Motavalli R; Etemadi J; Eghbal-Fard S; Aghebati-Maleki L; Danaii S; Taghavi S; Yousefi M
Hum Immunol; 2022; 83(8-9):628-636. PubMed ID: 35906120
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.
Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E
Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of PD-1 and Tim-3 expression besides their related miRNAs in PBMCs of women with recurrent pregnancy loss.
Ahmadi H; Soltani-Zangbar MS; Yousefi M; Baradaran B; Bromand S; Aghebati-Maleki L; Szekeres-Bartho J
Immunol Lett; 2024 Apr; 266():106837. PubMed ID: 38266686
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survival.
Tu L; Guan R; Yang H; Zhou Y; Hong W; Ma L; Zhao G; Yu M
Int J Cancer; 2020 Jul; 147(2):423-439. PubMed ID: 31721169
[TBL] [Abstract][Full Text] [Related]
5. Analysis of TCR Repertoire and PD-1 Expression in Decidual and Peripheral CD8
Morita K; Tsuda S; Kobayashi E; Hamana H; Tsuda K; Shima T; Nakashima A; Ushijima A; Kishi H; Saito S
Front Immunol; 2020; 11():1082. PubMed ID: 32582176
[TBL] [Abstract][Full Text] [Related]
6. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
Linedale R; Schmidt C; King BT; Ganko AG; Simpson F; Panizza BJ; Leggatt GR
PLoS One; 2017; 12(4):e0175755. PubMed ID: 28423034
[TBL] [Abstract][Full Text] [Related]
7. A newly intervention strategy in preeclampsia: Targeting PD-1/Tim-3 signaling pathways to modulate the polarization of decidual macrophages.
Hu XH; Li ZH; Muyayalo KP; Wang LL; Liu CY; Mor G; Liao AH
FASEB J; 2022 Jan; 36(1):e22073. PubMed ID: 34847253
[TBL] [Abstract][Full Text] [Related]
8. The abnormal expression of Tim-3 is involved in the regulation of myeloid-derived suppressor cells and its correlation with preeclampsia.
Dong S; Shah NK; He J; Han S; Xie M; Wang Y; Cheng T; Liu Z; Shu C
Placenta; 2021 Oct; 114():108-114. PubMed ID: 34509865
[TBL] [Abstract][Full Text] [Related]
9. Expression of the immune checkpoint receptors CTLA-4, LAG-3, and TIM-3 in β-thalassemia major patients: correlation with alloantibody production and regulatory T cells (Tregs) phenotype.
Shokrgozar N; Karimi M; Golmoghaddam H; Rezaei N; Moayed V; Sharifzadeh S; Arandi N
Ann Hematol; 2021 Oct; 100(10):2463-2469. PubMed ID: 34324022
[TBL] [Abstract][Full Text] [Related]
10. The appropriate frequency and function of decidual Tim-3
Wang S; Sun F; Li M; Qian J; Chen C; Wang M; Zang X; Li D; Yu M; Du M
Cell Death Dis; 2019 May; 10(6):407. PubMed ID: 31138782
[TBL] [Abstract][Full Text] [Related]
11. Not All Immune Checkpoints Are Created Equal.
De Sousa Linhares A; Leitner J; Grabmeier-Pfistershammer K; Steinberger P
Front Immunol; 2018; 9():1909. PubMed ID: 30233564
[TBL] [Abstract][Full Text] [Related]
12. The Role of the Immune Checkpoint Molecules PD-1/PD-L1 and TIM-3/Gal-9 in the Pathogenesis of Preeclampsia-A Narrative Review.
Mittelberger J; Seefried M; Franitza M; Garrido F; Ditsch N; Jeschke U; Dannecker C
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208481
[TBL] [Abstract][Full Text] [Related]
13. Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.
Hu X; Zhu Q; Wang Y; Wang L; Li Z; Mor G; Liao A
Hum Reprod; 2020 Nov; 35(11):2454-2466. PubMed ID: 33107565
[TBL] [Abstract][Full Text] [Related]
14. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface.
Wang S; Zhu X; Xu Y; Zhang D; Li Y; Tao Y; Piao H; Li D; Du M
Hum Reprod; 2016 Apr; 31(4):700-11. PubMed ID: 26908841
[TBL] [Abstract][Full Text] [Related]
15. Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients.
Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Frydecka I; Pawlak E; Szmyrka M; Kosmaczewska A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502204
[TBL] [Abstract][Full Text] [Related]
16. Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.
Al-Badran SS; Grant L; Campo MV; Inthagard J; Pennel K; Quinn J; Konanahalli P; Hayman L; Horgan PG; McMillan DC; Roxburgh CS; Roseweir A; Park JH; Edwards J
J Pathol Clin Res; 2021 Mar; 7(2):121-134. PubMed ID: 33338327
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoints and reproductive immunology: Pioneers in the future therapy of infertility related Disorders?
Mohamed Khosroshahi L; Parhizkar F; Kachalaki S; Aghebati-Maleki A; Aghebati-Maleki L
Int Immunopharmacol; 2021 Oct; 99():107935. PubMed ID: 34304000
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy.
Motavalli R; Hosseini M; Soltani-Zangbar MS; Karimi A; Sadeghi M; Dolati S; Yousefi M; Etemadi J
Mol Cell Probes; 2023 Jun; 69():101914. PubMed ID: 37075987
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4
Wang S; Chen C; Li M; Qian J; Sun F; Li Y; Yu M; Wang M; Zang X; Zhu R; Li D; Du M
Cell Death Dis; 2019 Jan; 10(1):15. PubMed ID: 30622243
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer.
Su Y; Yamazaki S; Morisue R; Suzuki J; Yoshikawa T; Nakatsura T; Tsuboi M; Ochiai A; Ishii G
Pathobiology; 2021; 88(3):218-227. PubMed ID: 33321503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
